Evaluation of Vitreous Modifications After Cataract Surgery (VitCat)

September 11, 2026 updated by: Marco Rocco Pastore, University of Trieste

Assessment of Vitreous Changes Following Cataract Surgery

This study aims to evaluate changes in vitreous structure and the vitreoretinal interface following cataract surgery using spectral-domain optical coherence tomography (OCT). Patients undergoing cataract surgery will undergo standardized OCT imaging before and after surgery. Preoperative and postoperative images will be compared to identify and characterize qualitative and quantitative changes in vitreous morphology, with particular attention to the posterior vitreous and its relationship with the retinal surface.

Study Overview

Detailed Description

Cataract surgery may induce anatomical and biomechanical changes within the vitreous body and at the vitreoretinal interface. However, the extent and characteristics of these modifications remain incompletely defined, particularly when assessed using high-resolution optical coherence tomography (OCT).

The aim of this study is to investigate structural changes in the vitreous and vitreoretinal interface occurring after cataract surgery through a standardized preoperative and postoperative spectral-domain OCT imaging protocol.

Patients with cataract scheduled for surgery will be considered for inclusion. Eligible participants must have OCT images of sufficient quality for reliable assessment and no evidence of posterior vitreous detachment (PVD) at baseline. Both preoperative and postoperative OCT imaging must be available for comparative analysis.

Standardized OCT acquisition will include the 18 Line R64 and AS Star 18 Line R16 imaging protocols using the Dream OCT platform. These scans will be used to assess the posterior vitreous, its relationship with the retinal surface, and any postoperative changes in vitreous morphology or vitreoretinal interface configuration.

Preoperative and postoperative images will be compared both qualitatively and quantitatively. The analysis will focus on identifying changes in the visibility, configuration, position, and attachment of the posterior vitreous structures, as well as any modifications of the vitreoretinal interface occurring following cataract surgery.

Patients will be excluded in the presence of factors that may interfere with accurate vitreous assessment or independently alter vitreoretinal anatomy. These include advanced cataract significantly compromising OCT image quality, pre-existing posterior vitreous detachment, previous vitreous hemorrhage, previous vitreoretinal surgery, prior intravitreal injections, retinal diseases affecting evaluation of the vitreoretinal interface, pathologic high myopia, and a history of ocular trauma or uveitis.

The primary objective is to quantitatively and qualitatively characterize postoperative changes in vitreous morphology and vitreoretinal interface features after cataract surgery. The study is intended to improve understanding of the early structural effects of cataract surgery on the vitreous and to determine whether OCT imaging can reliably document these postoperative modifications.

Study Type

Observational

Enrollment (Estimated)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Paris
      • Créteil, Paris, France, 94000
        • Recruiting
        • Centre Hospitalier Intercommunal de Créteil
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled for cataract surgery without posterior vitreous detachment

Description

Inclusion Criteria:

  • Presence of cataract scheduled for surgery
  • Adequate image acquisition quality
  • Absence of posterior vitreous detachment (PVD)
  • Availability of both preoperative and postoperative OCT imaging

Exclusion Criteria:

  • Advanced cataract significantly compromising image quality
  • Presence of posterior vitreous detachment (PVD)

    • History of vitreous hemorrhage
    • Previous vitreoretinal surgery
    • Previous intravitreal injections (IVT)
    • Retinal diseases affecting vitreoretinal interface assessment
    • Pathologic high myopia
    • History of ocular trauma or uveitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
No vitreous detachment
Patients scheduled for cataract surgery without posterior vitreous detachment
standard cataracte surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Postoperative Changes in Vitreous Morphology or Vitreoretinal Interface Configuration
Time Frame: 4 weeks
Preoperative and postoperative OCT images will be compared to identify participants showing structural changes in the posterior vitreous or vitreoretinal interface, including changes in posterior hyaloid position, vitreoretinal attachment status, and the development of partial or complete posterior vitreous detachment (PVD). Results will be reported as the number and proportion of participants presenting these postoperative changes.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2026

Primary Completion (Estimated)

September 20, 2026

Study Completion (Estimated)

October 20, 2026

Study Registration Dates

First Submitted

September 3, 2026

First Submitted That Met QC Criteria

September 11, 2026

First Posted (Actual)

September 14, 2026

Study Record Updates

Last Update Posted (Actual)

September 14, 2026

Last Update Submitted That Met QC Criteria

September 11, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual participant data are not planned to be publicly shared. However, fully anonymized data may be considered for sharing with qualified researchers upon reasonable request, subject to applicable ethical, institutional, and data protection requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe